Yeah. It really all depends on the doctors prescribing it. Other than the academics who were involved in the study, I haven't seen an overwhelming response to the drug from the sarcoma community.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.